Skip to search formSkip to main content

dasatinib 140 MG Oral Tablet [Sprycel]

Known as: SPRYCEL 140 MG Oral Tablet 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Dasatinib (Sprycel®, Bristol-Myers Squibb) is an oral potent ATP-competitive multikinase inhibitor active against BCR-ABL and SRC… Expand
Is this relevant?
2006
2006
Dasatinib (SPRYCEL®, formerly BMS-354825) is a novel, oral, multi-targeted kinase inhibitor that induces complete hematologic and… Expand
Is this relevant?
2006
2006
Pts with CML resistant to im have few therapeutic options. A growing body of evidence suggests that treatment outcomes can be… Expand
Is this relevant?